Dynamics of T cell activation accompanying CD4 recovery in antiretroviral treated HIV-infected Ugandan children

被引:6
|
作者
Ruel, Theodore [1 ]
Ssewanyana, Isaac [2 ]
Achan, Jane [3 ]
Gasasira, Anne [4 ]
Kamya, Moses R. [3 ]
Kekitiinwa, Adeodata [5 ]
Wong, Joseph K.
Cao, Huyen [6 ]
Havlir, Diane
Charlebois, Edwin D.
机构
[1] Univ Calif San Francisco, Dept Pediat, Div Infect Dis, San Francisco, CA 94143 USA
[2] Joint Clin Res Ctr, Kampala, Uganda
[3] Makerere Univ, Fac Med, Kampala, Uganda
[4] Univ Calif Berkeley, Berkeley, CA 94720 USA
[5] Mulago Hosp, Paediat Infect Dis Clin, Baylor Coll Med, Kampala, Uganda
[6] Calif Dept Publ Hlth, Richmond, CA USA
关键词
T cell activation; Children; Antiretroviral treatment; Uganda; IMMUNE ACTIVATION; VIRAL LOAD; IMMUNOLOGICAL RESPONSE; THERAPY; IMMUNODEFICIENCY; SUBSETS; MALARIA; PROFILE; AGE;
D O I
10.1016/j.clim.2009.01.016
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Africans have elevated T cell activation compared to residents of Europe or the USA. Levels of T cell activation also correlate with disease progression in HIV-infected individuals. We sought to determine if treatment with antiretroviral therapy (ART) would reduce levels of T cell activation (CD38 and HLADR co-expression) in HIV-infected Ugandan children. The median CD8+ T cell activation level among 199 ART-treated children (30%) was lower than in 57 ART-naive children (45%, p<0.001), but remained higher than in 30 HIV-uninfected children (18%, p<0.001). Among ART-treated children, CD4% was inversely correlated with both CD8- (rho=-0.61, p<0.001) and CD8+ (rho=-0.38, p<0.001) T cell activation. Prospectively, CD4 recovery correlated with post-treatment CD8+ T cell activation level (p=0.008). Our data suggest that significant decreases in T cell activation accompany CD4 recovery in ART-treated HIV-infected African children, to levels that approach but do not reach those of uninfected children. (C) 2009 Elsevier Inc. All rights reserved.
引用
收藏
页码:410 / 414
页数:5
相关论文
共 50 条
  • [41] CD4+ T-cell immunodeficiency is more dependent on immune activation than viral load in HIV-infected children on highly active antiretroviral therapy
    Resino, Salvador
    Seoane, Elena
    Gurbindo Gutierrez, Maria Dolores
    Antonio Leon, Juan
    Angeles Munoz-Fernandez, Maria
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2006, 42 (03) : 269 - 276
  • [42] Recall of Nadir CD4 Cell Count and Most Recent HIV Viral Load Among HIV-Infected, Socially Marginalized Adults
    Buisker, Timothy R.
    Dufour, Mi-Suk Kang
    Myers, Janet J.
    AIDS AND BEHAVIOR, 2015, 19 (11) : 2108 - 2116
  • [43] Restoration of recent thymic emigrant CD4+ T cells is associated with sustained adherence to antiretroviral treatment in HIV-infected children
    Barboni, Graciela
    Balbaryski, Jeanette
    Urioste, Alejandra
    Candi, Marcela
    Laucella, Susana
    Gaddi, Eduardo
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2020, 91 (03)
  • [44] A Randomized, Controlled Trial of Raltegravir Intensification in Antiretroviral-treated, HIV-infected Patients with a Suboptimal CD4+ T Cell Response
    Hatano, Hiroyu
    Hayes, Timothy L.
    Dahl, Viktor
    Sinclair, Elizabeth
    Lee, Tzong-Hae
    Hoh, Rebecca
    Lampiris, Harry
    Hunt, Peter W.
    Palmer, Sarah
    McCune, Joseph M.
    Martin, Jeffrey N.
    Busch, Michael P.
    Shacklett, Barbara L.
    Deeks, Steven G.
    JOURNAL OF INFECTIOUS DISEASES, 2011, 203 (07) : 960 - 968
  • [45] Rosuvastatin Is Effective to Decrease CD8 T-Cell Activation Only in HIV-Infected Patients With High Residual T-Cell Activation Under Antiretroviral Therapy
    Weiss, Laurence
    Chevalier, Mathieu F.
    Assoumou, Lambert
    Paul, Jean-Louis
    Alhenc-Gelas, Martine
    Didier, Celine
    Taibi, Said
    Manea, Elena-Maria
    Campa, Pauline
    Girard, Pierre-Marie
    Costagliola, Dominique
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2016, 71 (04) : 390 - 398
  • [46] Response to Antiretroviral Therapy in HIV-Infected Ugandan Children Exposed and Not Exposed to Single-Dose Nevirapine at Birth
    Musoke, Philippa M.
    Barlow-Mosha, Linda
    Bagenda, Danstan
    Mudiope, Peter
    Mubiru, Michael
    Ajuna, Patrick
    Tumwine, James K.
    Fowler, Mary Glenn
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2009, 52 (05) : 560 - 568
  • [47] The Immunologic Effects of Mesalamine in Treated HIV-Infected Individuals with Incomplete CD4+T Cell Recovery: A Randomized Crossover Trial
    Somsouk, Ma
    Dunham, Richard M.
    Cohen, Michelle
    Albright, Rebecca
    Abdel-Mohsen, Mohamed
    Liegler, Teri
    Lifson, Jeffrey
    Piatak, Michael
    Gorelick, Robert
    Huang, Yong
    Wu, Yuaner
    Hsue, Priscilla Y.
    Martin, Jeffrey N.
    Deeks, Steven G.
    McCune, Joseph M.
    Hunt, Peter W.
    PLOS ONE, 2014, 9 (12):
  • [48] Age and CD4 count of vertically HIV-infected children at the time of diagnosis: what are independent predictors for being symptomatic and CD4 counts drop?
    Berhan, Yifru
    JOURNAL OF TROPICAL PEDIATRICS, 2011, 57 (01) : 14 - 23
  • [49] T cell apoptosis in HIV-infected patients with incomplete immune recovery after antiretroviral therapy
    Saidakova E.V.
    Korolevskaya L.B.
    Shmagel N.G.
    Shmagel K.V.
    Chereshnev V.A.
    Doklady Biological Sciences, 2013, 450 (1) : 189 - 191
  • [50] Polymorphisms in the CD14 and TLR4 genes independently predict CD4+ T-cell recovery in HIV-infected individuals on antiretroviral therapy
    Yong, Yean K.
    Shankar, Esaki M.
    Solomon, Ajantha
    Spelman, Tim
    Fairley, Christopher K.
    Elliott, Julian H.
    Hoy, Jennifer
    Cameron, Paul U.
    Kamarulzaman, Adeeba
    Lewin, Sharon R.
    AIDS, 2016, 30 (14) : 2159 - 2168